Lipid accumulation and transforming growth factor-β upregulation in the kidneys of rats administered angiotensin II
Lipid accumulation and transforming growth factor-β upregulation in the kidneys of rats administered angiotensin II
复制标题
DOI:
10.1161/01.hyp.0000184653.75036.d5
复制
发表时间:
2005-11-01
期刊:
影响因子:
8.3
通讯作者:
Nagai, R
中科院分区:
文献类型:
--
作者:
Saito, K;Ishizaka, N;Nagai, R
Abnormal lipid metabolism may play a role in progressive renal failure. We studied whether lipid accumulation occurs and whether lipid deposits are colocalized with transforming growth factor-beta 1 (TGF-beta 1) in the kidney of angiotensin II-infused animals. Oil red 0 staining showed marked lipid deposition in the tubular epithelial and vascular wall cells of angiotensin II-treated but not in norepinephrine-treated rats. Histological analyses showed that increased amounts of superoxide and intense TGF-beta 1 mRNA expression were present in lipid-positive tubular epithelial cells in angiotensin II-infused animals. Protein expression of sterol regulatory element-binding protein I (SREBP-1) and mRNA expression of fatty acid synthase in the kidney were approximate to 3 times and 1.5 times, respectively, higher in angiotensin II-treated rats than in controls. Treatment of angiotensin II-infused animals with an iron chelator, deferoxamine, attenuated the angiotensin II-induced increases in renal expression of SREBP-1 and fatty acid synthase and normalized the lipid content in the renal cortical tissues. Abnormal lipid metabolism may be associated with upregulation of TGF-beta 1 I expression and aberrant iron homeostasis in the kidneys of angiotensin II-infused animals.